Literature DB >> 907657

Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry.

A F LeRoy, M L Wehling, H L Sponseller, W S Friauf, R E Solomon, R L Dedrick, C L Litterst, T E Gram, A M Guarino, D A Becker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 907657     DOI： 10.1016/0006-2944(77)90089-8

Source DB:  PubMed          Journal:  Biochem Med        ISSN： 0006-2944


× No keyword cloud information.
  56 in total

Review 1.  The risks of handling cytotoxic drugs. I. Methods of testing exposure.

Authors:  G P Kaijser; W J Underberg; J H Beijnen
Journal:  Pharm Weekbl Sci       Date:  1990-12-14

2.  Pharmacokinetics of Irinotecan, Oxaliplatin and 5-Fluorouracil During Hepatic Artery Chronomodulated Infusion: A Translational European OPTILIV Study.

Authors:  Francis Lévi; Abdoulaye Karaboué; Marie-Christine Etienne-Grimaldi; Gilles Paintaud; Christian Focan; Pasquale Innominato; Mohamed Bouchahda; Gérard Milano; Etienne Chatelut
Journal:  Clin Pharmacokinet       Date:  2017-02       Impact factor: 6.447

3.  Cystatin C as a new covariate to predict renal elimination of drugs: application to carboplatin.

Authors:  Fabienne Thomas; Sophie Séronie-Vivien; Laurence Gladieff; Florence Dalenc; Valérie Durrand; Laurence Malard; Thierry Lafont; Muriel Poublanc; Roland Bugat; Etienne Chatelut
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

4.  Tumor-tissue and plasma concentrations of platinum during chemotherapy of non-small-cell lung cancer patients.

Authors:  J L Pujol; D Cupissol; C Gestin-Boyer; J Bres; B Serrou; F B Michel
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

5.  Platinum concentration in human tumors of head and neck, uterine cervix, and breast following treatment with cisplatin.

Authors:  B Hecquet; P Vennin; C Fournier; J L Lefebvre; A Caty; J Bonneterre; L Adenis; A Demaille
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

6.  Effects of the diuretics mannitol or acetazolamide on nephrotoxicity and physiological disposition of cisplatin in rats.

Authors:  N M Osman; M P Copley; C L Litterst
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

7.  Physiological model for the pharmacokinetics of cis-dichlorodiammineplatinum (II) (DDP) in the tumored rat.

Authors:  F F Farris; F G King; R L Dedrick; C L Litterst
Journal:  J Pharmacokinet Biopharm       Date:  1985-02

8.  Microcapsule chemoembolization for head and neck cancer.

Authors:  Y Okamoto; A Konno; K Togawa; T Kato; Y Amano
Journal:  Arch Otorhinolaryngol       Date:  1985

9.  Effects of intralesional injection of cisplatin dissolved in urografin and lipiodol on Ehrlich ascites tumor and normal tissues of CD-1 mice.

Authors:  J E Landrito; K Yoshiga; K Sakurai; K Takada
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

10.  Prediction of the antitumor activity of new platinum analogs based on their ex vivo pharmacodynamics as determined by bioassay.

Authors:  Y Sasaki; T Shinkai; K Eguchi; T Tamura; Y Ohe; T Ohmori; N Saijo
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.